Regenerative Medicine Market to Grow at 19.40% CAGR Amidst Rising Chronic Disease Prevalence
The global regenerative medicine market, valued at USD 34.6 billion in 2022, is anticipated to reach USD 194.9 billion by 2032, with a compound annual growth rate (CAGR) of 19.40% from 2023 to 2032. This market's growth is driven by several factors, including advancements in cell and gene therapies, increased funding from government and private sectors, and rising demand for personalized medicine. Significant investments in research and development, especially in oncology and cardiovascular segments, are also propelling the market forward. Recent developments highlight key collaborations and acquisitions, such as Bristol Myers Squibb's purchase of Celgene, which enhances its capabilities in…
- Date: May 20, 2024
- Author: Robert Shaw
- Category: PharmiWeb